RenovaCare

About:

RenovaCare is a biotechnology company focused on developing first-of-their-kind autologous (self-donated) stem cell therapies.

Website: https://www.renovacareinc.com/

Twitter/X: renovacareinc

Top Investors: Kalen Capital

Description:

RenovaCare, Inc., formerly Janus Resources, Inc., is a biotechnology company. The Company is focused on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The Company's initial products under development target skin. The Company, through RenovaCare Sciences Corp., offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). It is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma.

Total Funding Amount:

$17.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

1983-07-14

Contact Email:

info(AT)renovacareinc.com

Founders:

Jörg Gerlach

Number of Employees:

1-10

Last Funding Date:

2018-11-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai